BIOVAIL TO PROMOTE NOVARTIS' LESCOL FRANCHISE IN CANADA

Biovail Corporation today announced that Biovail Pharmaceuticals Canada (BPC), the Company's Canadian sales and marketing division, has entered into an agreement with Novartis Pharmaceuticals Canada Inc., a wholly owned subsidiary of Novartis AG, to market and promote cholesterol medicines Lescol, fluvastatin sodium capsules, and once-daily Lescol XL, fluvastatin sodium extended-release tablets, to Canadian specialists and primary-care physicians.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060519005116&newsLang=en)